SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : The New Economy and its Winners

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bill Harmond who wrote (7135)5/24/2001 2:05:39 AM
From: Libbyt  Read Replies (1) of 57684
 
Anyone following Genome?

I haven't followed some of the biotech companies for awhile, but the volume in GENE caught my attention! I went back and did some research on the company, since I remember discussing GENE about 18 months ago? (can't remember the exact timing.) At the time, quite a few people were investing in CRA, and at the time IMO GENE offered an advantage when compared to other companies involved with genetic research.

GENE is involved with gene sequencing of bacteria and viruses. Their research attempts to discover the drugs and chemicals that alter and kill the bacteria or virus. This research information on the sequencing of genes can then be sold to the large pharmaceutical companies The pharmaceutical company then uses this information to try to develop new antibiotics. Compared to other companies, the risk of developing the actual drugs is to the pharmaceutical companies, and not to GENE...since they are providing the research, and not the actual development of the drugs.

It sounds like a case of "dueling analysts"....with two different opinions on this company, but IMO compared to some of the other companies dealing with genetic research, GENE seems to offer a lot of potential.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext